I'm LongbridgeAI, I can summarize articles.CollPlant Biotechnologies (CLGN.US) surged more than 16% during regular trading to $4.60.
The stock is up 16.75% over the past five sessions and down 67.14% year to date. It sits 74.44% above its 52-week low of US$2.637. Volume was 6.58 times its average and the intraday swing reached 13.89%.
The Nasdaq Composite is up 4.22% over the past five sessions and up 9.03% year to date.
Subsidiary LightSolver received a grant of about $1.8 million from the Israel Innovation Authority on Nov. 5 to advance commercialization of its laser processing unit. Separately, it signed a multi-year contract with the Israeli Ministry of Defense on Oct. 29 to develop and deliver the LPU.
The company appointed Chief Financial Officer Eran Rotem as chief executive officer on Nov. 2, succeeding Yehiel Tal. The leadership change is part of a broader cost-reduction strategy that includes halting research and development in regenerative medicine.
Based on public media reports. AI-generated; not investment advice.